TickerFactsScreenerDevelopers

Karyopharm Therapeutics Inc. (KPTI) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2013: $3.29M2014: $13.54M2015: $17.08M2016: $18.14M2017: $50.83M2018: $158.02M2019: $245.19M2020: $262.50M2021: $384.98M2022: $374.83M2023: $376.64M2024: $350.44M2025: $401.34M$401.34M
2013Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$401.34M+14.5%
2024$350.44M-7.0%
2023$376.64M+0.5%
2022$374.83M-2.6%
2021$384.98M+46.7%
2020$262.50M+7.1%
2019$245.19M+55.2%
2018$158.02M+210.9%
2017$50.83M+180.2%
2016$18.14M+6.2%
2015$17.08M+26.1%
2014$13.54M+311.4%
2013$3.29M—